Ugoos X5M Pro is a TV box based on Amlogic S905X5M chipset, which is one of the new budget chipsets from Amlogic (no VCC/H.266 support for instance). This box is similar if not identical to it’s older brothers from X4 family (reviewed here in the past), and the specs are simply upgraded. Aside for BT …
Ugoos AM9 is Ugoos’ newest offering, but like with SK series (SK1 to SK2), it takes a step back. From the powerful AM6 Pro and the AM8 (not sure where AM7 went), it goes to a cheaper chipset (Amlogic S905X5) with lighter specs. Many thanks goes to James from Ugoos for providing the AM9 Review …
Ugoos SK2 is Ugoos’ new budget Android TV box, and it’s a bit different than their other boxes. The biggest difference is the OS. SK2 uses Google Android TV at its core, and a realtek RTD1325 chipset. All of that is done to keep costs down, while still including licensing for the big streaming services. …
We are living through a paradigm shift in how we prove we are who we say we are online. Instead of asking What do you know? (password, PIN, mother’s maiden name) or What do you look like? (Face ID, fingerprint) the question has become How do you behave? The post Behavior is the New Credential …
Google Photos has officially begun removing several “hidden” gesture-based editing shortcuts within its Android application. These intuitive interactions, which allowed users to quickly access advanced Artificial Intelligence (AI) tools directly on an image, are being phased out in favor of a more standardized menu-driven experience. The Removal of Intuitive Gestures Until recently, Google Photos on …
Samsung has officially announced the discontinuation of its proprietary messaging application, Samsung Messages, in the United States. Effective July 2026, the service will reach its end-of-life phase as the company transitions its ecosystem entirely to Google Messages. The “End of Service” notice specifically impacts Galaxy users running Android 12 and newer. While older legacy devices …
Nature Medicine, Published online: 06 April 2026; doi:10.1038/s41591-026-04282-0 In the phase 3 EMN24 IsKia trial, transplant-eligible patients with newly diagnosed multiple myeloma who received isatuximab with carfilzomib, lenalidomide and dexamethasone pretransplant induction and post-transplant consolidation showed higher rates of measurable residual disease negativity after consolidation than patients who received carfilzomib, lenalidomide and dexamethasone. Read More
A new way to build vector RAG—structure-aware and reasoning-capable The post Proxy-Pointer RAG: Achieving Vectorless Accuracy at Vector RAG Scale and Cost appeared first on Towards Data Science. Read More